Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Deloitte
Four Out of 10 Global Executives Reluctant to Disclose Significant Corruption Incident to Authorities
February 22nd, 2009
In a Deloitte survey of 329 executives from around the world, 41 percent of respondents indicated that senior management should investigate and deal with matters internally or wait to see if there are consequences rather than make a voluntary disclosure to authorities if a significant incident of corruption was uncovered at their organizations. The study, titled Fortifying Anti-Corruption in Today's Corporation, also revealed that despite differing views about disclosure, the vast majority of those surveyed (93 percent) believe that an internal investigation should be conducted if a significant incident of corruption were uncovered, and 75 percent support zero tolerance...
Source: Pharma Investments, Ventures & Law Weekly (2009-02-22)
|
